Mesoblast
MESO
#4332
Rank
HK$18.79 B
Marketcap
HK$145.99
Share price
3.59%
Change (1 day)
73.11%
Change (1 year)

Mesoblast (MESO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : HK$1.45 Billion

According to Mesoblast 's latest financial reports the company's total liabilities are HK$1.45 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mesoblast - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30HK$1.47 B12.27%
2023-06-30HK$1.31 B1.36%
2022-06-30HK$1.29 B2.17%
2021-06-30HK$1.26 B-11.21%
2020-06-30HK$1.42 B6.88%
2019-06-30HK$1.33 B16.28%
2018-06-30HK$1.14 B5.97%
2017-06-30HK$1.08 B-10.33%
2016-06-30HK$1.20 B-50.27%
2015-06-30HK$2.43 B-4.21%
2014-06-30HK$2.53 B29.16%
2013-06-30HK$1.96 B4.88%
2012-06-30HK$1.87 B-2.65%
2011-06-30HK$1.92 B15393.87%
2010-06-30HK$12.42 M35.31%
2009-06-30HK$9.18 M-25.11%
2008-06-30HK$12.26 M124.5%
2007-06-30HK$5.46 M-84.31%
2006-06-30HK$34.81 M103.37%
2005-06-30HK$17.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
HK$0.94 B-35.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
HK$24.49 M-98.32% Bahamas